ES00 | A complete E-Mini S&P 500 Future Continuous Contract futures overview by MarketWatch. View the futures and commodity market news, futures pricing and futures trading.

S&P 500 Today: Get all information on the S&P 500 Index including historical chart, news and constituents.

S&P 500 Market Movers. Find the S&P 500 hot stocks to buy today. S&P 500 Top market gainers and losers today.

Information on Parkinson's disease. Learn about Parkinson's disease treatments, symptoms, new research and medication.

Nonetheless, though Keytruda will lose patent exclusivity in 2028, its sales are expected to remain strong until then. Merck is also working on different strategies to drive Keytruda's long-term ...

Loe’s six seasons for the Breakers included the 2020-21 and ‘21-22 campaigns where the team was based out of Australia because of Covid.

Will Merck's Keytruda Continue to Drive Growth Amid Looming LOE? June 10, 2025 — 09:46 am EDT. Written by Kinjel Shah for Zacks-> Merck MRK boasts more than six blockbuster drugs in its ...

The community effort and attention around “Sinners,” a blockbuster horror movie, became an opportunity to talk about investing in the Delta town that built the blues.

Wildfires are forecast to continue and expand through the summer in Western Canada and parts of the country’s north.

With Keytruda accounting for a substantial portion of the company’s sales, the projected 10-20% decline post-LOE could create a substantial gap in Merck’s financial performance.